The Canada legal cannabis market size is expected to reach USD 5.79 billion by 2030, registering a CAGR of 10.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing awareness of the health benefits related to cannabis and CBD consumption for treating anxiety & seizures and reducing pain is projected to propel the market growth. The high demand for CBD for health and wellness purposes, attributed to its therapeutic properties, is a key driver in the market's growth.
Moreover, the rising number of clinical trials signifies the positive effects of utilizing cannabis for treating various medical conditions. For instance, in February 2024, researchers at the University of British Columbia introduced a first-of-its-kind clinical trial examining the potential of CBD as a treatment for bipolar depression. The trials were approved by Health Canada and funded by the Canadian Institutes of Health Research (CIHR) to investigate how CBD can help manage acute bipolar depression.
Moreover, medical professionals' increasing preference for cannabinoid-based formulations to treat numerous health conditions is another major factor supporting the country's market. Healthcare professionals' higher preference for CBG, CBN-derived products creates a positive influence on consumer minds, thereby boosting their adoption rate and popularity. For instance, in October 2021, Cronos Group Inc. launched its SPINACH FEELZ Chill Bliss 2:1 THC|CBG gummy that features THC and cultured CBG.
Some of the key players in the market are Canopy Growth Corporation, Charlotte's Web, Inc., Aurora Cannabis, Tilray Brands, The Cronos Group, Jazz Pharmaceuticals, Inc., Sundial Growers, and Maricann, Inc. These market players adopt key strategic initiatives to expand their business footprint and market position. For instance, in April 2023, Aurora Cannabis Inc. partnered with Strainprint and announced the launch of the tracking program through Strainprint App. The tracking program is designed for Aurora patients to keep track of their medical cannabis journey.
Furthermore, the rise in awareness regarding cannabis and its potential use in various industries and the introduction of educational programs boost the market growth. For instance, in July 2022, Tilray Brands launched a cannabis education platform, WeCare-Medical Cannabis. The platform is dedicated to educating patients and healthcare practitioners about medical cannabis.
Request a free sample copy or view report summary: Canada Legal Cannabis Market Report
Based on source, the marijuana segment dominated the market in 2023 and is anticipated to witness the fastest growth over the forecast period owing to the growing adoption of marijuana-based products
Based on derivatives, the CBD segment held the largest market share in 2023, owing to the awareness regarding CBD's effectiveness in treating various medical conditions
Based on cultivation, the indoor segment held the largest market share in 2023 due to the incorporation of artificial intelligence (AI) in cannabis cultivation, rising investments, and favorable government initiatives
Based on end use, the recreational segment dominated the market in 2023 and is anticipated to grow at the fastest CAGR over the forecast period due to the growing consumption of cannabis in the form of vapes, foods, and beverages
Grand View Research has segmented the Canada legal cannabis market on the basis of source, derivatives, cultivation, end-use, and region:
Canada Legal Cannabis Source Outlook (Revenue, USD Million, 2018 - 2030)
Marijuana
Flowers
Oil And Tinctures
Hemp
Hemp Oil
Industrial Hemp
Canada Legal Cannabis Derivatives Outlook (Revenue, USD Million, 2018 - 2030)
CBD
THC
Others
Canada Legal Cannabis Cultivation Outlook (Revenue, USD Million, 2018 - 2030)
Indoor Cultivation
Greenhouse Cultivation
Outdoor Cultivation
Canada Legal Cannabis End-use Outlook (Revenue, USD Million, 2018 - 2030)
Medical Use
Cancer
Chronic Pain
Depression And Anxiety
Arthritis
Diabetes
Glaucoma
Migraines
Epilepsy
Multiple Sclerosis
AIDS
Amyotrophic Lateral Sclerosis
Alzheimer’s
Post-Traumatic Stress Disorder (PTSD)
Parkinson's
Tourette’s
Others
Recreational Use
Industrial Use
List of Key Players in the Canada Legal Cannabis Market
Canopy Growth Corporation
Charlotte's Web, Inc.
Aurora Cannabis Inc.
Tilray Brands
The Cronos Group
Jazz Pharmaceuticals, Inc.
Sundial Growers
Organigram Holding, Inc.
Maricann, Inc.
Isodiol International, Incl
"The quality of research they have done for us has been excellent..."